203 related articles for article (PubMed ID: 22335515)
1. New perspectives in antiplatelet therapy.
Tello-Montoliu A; Jover E; Rivera J; Valdés M; Angiolillo DJ; Marín F
Curr Med Chem; 2012; 19(3):406-27. PubMed ID: 22335515
[TBL] [Abstract][Full Text] [Related]
2. Advances in antiplatelet therapy.
Michelson AD
Hematology Am Soc Hematol Educ Program; 2011; 2011():62-9. PubMed ID: 22160013
[TBL] [Abstract][Full Text] [Related]
3. Platelet receptors as therapeutic targets: Past, present and future.
Jamasbi J; Ayabe K; Goto S; Nieswandt B; Peter K; Siess W
Thromb Haemost; 2017 Jun; 117(7):1249-1257. PubMed ID: 28597906
[TBL] [Abstract][Full Text] [Related]
4. [Antiplatelet agents].
Steg G
Bull Acad Natl Med; 2013 Feb; 197(2):375-87; discussion 387-8. PubMed ID: 24919367
[TBL] [Abstract][Full Text] [Related]
5. Acute and long-term antiplatelet therapy.
Papathanasiou AI; Goudevenos JA; Mikhailidis DP; Tselepis AD
Drugs Today (Barc); 2008 May; 44(5):331-52. PubMed ID: 18548136
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
Jennings LK
Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
[TBL] [Abstract][Full Text] [Related]
7. Oral antiplatelet therapy for atherothrombotic disease: current evidence and new directions.
White HD
Am Heart J; 2011 Mar; 161(3):450-61. PubMed ID: 21392598
[TBL] [Abstract][Full Text] [Related]
8. Platelet thrombin receptor antagonism and atherothrombosis.
Angiolillo DJ; Capodanno D; Goto S
Eur Heart J; 2010 Jan; 31(1):17-28. PubMed ID: 19948715
[TBL] [Abstract][Full Text] [Related]
9. Protease-Activated Receptor 1 Inhibitors: Novel Antiplatelet Drugs in Prevention of Atherothrombosis.
Al-Khafaji K; Mutyala M; Al-Khafaji N; Harper Y; Ismail I; Hakim H; Arora RR
Am J Ther; 2017; 24(6):e730-e736. PubMed ID: 26398717
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet drugs in cardiological practice: established strategies and new developments.
Krötz F; Sohn HY; Klauss V
Vasc Health Risk Manag; 2008; 4(3):637-45. PubMed ID: 18827913
[TBL] [Abstract][Full Text] [Related]
11. Combination antiplatelet treatment in coronary artery disease patients: A necessary evil or an overzealous practice?
Alexopoulos D; Katogiannis K; Sfantou D; Lekakis J
Platelets; 2018 May; 29(3):228-237. PubMed ID: 29022423
[TBL] [Abstract][Full Text] [Related]
12. [Mechanisms of platelet activation and development of antiplatelet agents].
Cazenave JP; Gachet C; Lanza F
Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1501-6. PubMed ID: 9092410
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
Judge HM; Buckland RJ; Holgate CE; Storey RF
Platelets; 2005 Nov; 16(7):398-407. PubMed ID: 16236601
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet therapy in patients with diabetes mellitus.
Grove EL; Gregersen S
Curr Vasc Pharmacol; 2012 Jul; 10(4):494-505. PubMed ID: 22272895
[TBL] [Abstract][Full Text] [Related]
16. Platelet function testing and implications for clinical practice.
Collet JP; Montalescot G
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):157-69. PubMed ID: 19721130
[TBL] [Abstract][Full Text] [Related]
17. Use of antiplatelet agents in sepsis: a glimpse into the future.
Akinosoglou K; Alexopoulos D
Thromb Res; 2014 Feb; 133(2):131-8. PubMed ID: 24103487
[TBL] [Abstract][Full Text] [Related]
18. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.
Lecut C; Schoolmeester A; Kuijpers MJ; Broers JL; van Zandvoort MA; Vanhoorelbeke K; Deckmyn H; Jandrot-Perrus M; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1727-33. PubMed ID: 15231520
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet agents.
Varon D; Spectre G
Hematology Am Soc Hematol Educ Program; 2009; ():267-72. PubMed ID: 20008209
[TBL] [Abstract][Full Text] [Related]
20. Platelet biology and implications for antiplatelet therapy in atherothrombotic disease.
Montalescot G
Clin Appl Thromb Hemost; 2011 Aug; 17(4):371-80. PubMed ID: 20566574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
